NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease

Mediators of Inflammation

Volumn 2017, Issue , 2017, Pages

  Guo, Honglei ^a   Bi, Xiao ^b   Zhou, Ping ^c   Zhu, Shijian ^b   Ding, Wei ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; NLRP3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTRACELLULAR MATRIX; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY STRUCTURE; MALE; MOUSE; NLRP3 DEFICIENCY; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN FUNCTION; TISSUE INJURY; ULTRASTRUCTURE; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; FIBROSIS; GENETICS; IMMUNOLOGY; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; INFLAMMASOMES; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; URETERAL OBSTRUCTION;

EID: 85015799617     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2017/8316560     Document Type: Article

References (34)

1. V. Jha, G. Garcia-Garcia, K. Iseki, et al., "Chronic kidney disease: global dimension and perspectives, " The Lancet, vol. 382, no. 9888, pp. 260-272, 2013.
2. T. J. Hoerger, S. A. Simpson, B. O. Yarnoff, et al., "The future burden of CKD in the United States: a simulation model for the CDC CKD initiative, " American Journal of Kidney Diseases, vol. 65, no. 3, pp. 403-411, 2015.
3. N. Ledo, Y.-A. Ko, A.-S. D. Park, et al., "Functional genomic annotation of genetic risk loci highlights inflammation and epithelial biology networks in CKD, " Journal of the American Society of Nephrology, vol. 26, no. 3, pp. 692-714, 2015.
4. D. Impellizzeri, E. Esposito, J. Attley, S. Cuzzocrea, "Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD), " Pharmacological Research, vol. 81, pp. 91-102, 2014.
5. D. L. Mattson, "Infiltrating immune cells in the kidney in saltsensitive hypertension and renal injury, " American Journal of Physiology-Renal Physiology, vol. 307, no. 5, pp. F499-F508, 2014.
6. C. M. Artlett and J. D. Thacker, "Molecular activation of the NLRP3 inflammasome in fibrosis: common threads linking divergent fibrogenic diseases, " Antioxidants and Redox Signaling, vol. 22, no. 13, pp. 1162-1175, 2015.
7. A. Vilaysane, J. Chun, M. E. Seamone, et al., "The NLRP3 inflammasome promotes renal inflammation and contributes to CKD, " Journal of theAmerican Society of Nephrology, vol. 21, no. 10, pp. 1732-1744, 2010.
8. W. P. Pulskens, L. M. Butter, G. J. Teske, et al., "Nlrp3 prevents early renal interstitial edema and vascular permeability in unilateral ureteral obstruction, " PLoS ONE, vol. 9, no. 1, Article ID e85775, 2014.
9. K. Chen, J. Zhang, W. Zhang, et al., "ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy, " International Journal of Biochemistry and Cell Biology, vol. 45, no. 5, pp. 932-943, 2013.
10. S. Granata, V. Masola, E. Zoratti, et al., "NLRP3 inflammasome activation in dialyzed chronic kidney disease patients, " PLoS ONE, vol. 10, no. 3, Article IDe0122272, 2015.
11. W. Ding, H. Guo, C. Xu, B. Wang, M. Zhang, F. Ding, "Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury, " Oncotarget, vol. 7, no. 14, pp. 17479-17491, 2016.
12. M. Tamaki, K. Miyashita, S. Wakino, M. Mitsuishi, K. Hayashi, H. Itoh, "Chronic kidney disease reducesmuscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase, " Kidney International, vol. 85, no. 6, pp. 1330-1339, 2014.
13. J. L. Gamboa, F. T. Billings, M. T. Bojanowski, et al., "Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease, " Physiological Reports, vol. 4, no. 9, Article ID e12780, 2016.
14. S. Granata, G. Zaza, S. Simone, et al., "Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease, " BMC Genomics, vol. 10, article 388, 2009.
15. T. Ide, H. Tsutsui, S. Hayashidani, et al., "Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction, " Circulation Research, vol. 88, no. 5, pp. 529-535, 2001.
16. W. Ding, C. Xu, B. Wang, M. Zhang, "Rotenone attenuates renal injury in aldosterone-infused rats by inhibiting oxidative stress, mitochondrial dysfunction, inflammasome activation, " Medical Science Monitor, vol. 21, pp. 3136-3143, 2015.
17. R. L. Chevalier, M. S. Forbes, B. A. Thornhill, "Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy, " Kidney International, vol. 75, no. 11, pp. 1145-1152, 2009.
18. W. Ding, B. Wang, M. Zhang, Y. Gu, "Involvement of endoplasmic reticulum stress in uremic cardiomyopathy: protective effects of tauroursodeoxycholic acid, " Cellular Physiology and Biochemistry, vol. 38, no. 1, pp. 141-152, 2016.
19. B. Wang, W. Ding, M. Zhang, H. Li, Y. Gu, "Rapamycin attenuates aldosterone-induced tubulointerstitial inflammation and fibrosis, " Cellular Physiology and Biochemistry, vol. 35, no. 1, pp. 116-125, 2015.
20. C. Xu, W. Ding, L. Yang, M. Yang, M. Zhang, Y. Gu, "Contributions of endoplasmic reticulum stress and reactive oxygen species to renal injury in aldosterone/salt-induced rats, " Nephron-Experimental Nephrology, vol. 126, no. 1, pp. 25-32, 2014.
21. W. Ding, B. Wang, M. Zhang, Y. Gu, "Tempol, a superoxide dismutase-mimetic drug, ameliorates progression of renal disease in CKD mice, " Cellular Physiology and Biochemistry, vol. 36, no. 6, pp. 2170-2182, 2015.
22. M. Lech, R. Grbmayr, M. Ryu, et al., "Macrophage phenotype controls long-term AKI outcomes-kidney regeneration versus atrophy, " Journal of the American Society of Nephrology, vol. 25, no. 2, pp. 292-304, 2014.
23. H.-J. Anders and D. A. Muruve, "Theinflammasomes in kidney disease, " Journal of the American Society of Nephrology, vol. 22, no. 6, pp. 1007-1018, 2011.
24. G. Lonnemann, D. Novick, M. Rubinstein, C. A. Dinarello, "Interleukin-18, interleukin-18 binding protein and impaired production of interferon-g in chronic renal failure, " Clinical Nephrology, vol. 60, no. 5, pp. 327-334, 2003.
25. A. H. Bani-Hani, J. A. Leslie, H. Asanuma, et al., "IL-18 neutralization ameliorates obstruction-induced epithelialmesenchymal transition and renal fibrosis, " Kidney International, vol. 76, no. 5, pp. 500-511, 2009.
26. J.-F. Chen, H. Liu, H.-F. Ni, et al., "Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats, " PLoS ONE, vol. 8, no. 12, Article IDe83593, 2013.
27. M. Pinto and C. T. Moraes, "Mechanisms linking mtDNA damage and aging, " Free Radical Biology and Medicine, vol. 85, pp. 250-258, 2015.
28. S. C. Lim, J. Hroudov, N. J. Van Bergen, M. I. G. Lopez Sanchez, I. A. Trounce, M. McKenzie, "Loss of mitochondrial DNA-encoded protein ND1 results in disruption of complex I biogenesis during early stages of assembly, " The FASEB Journal, vol. 30, no. 6, pp. 2236-2248, 2016.
29. J. Houstek, S. Kmoch, J. Zeman, "TMEM70 protein-a novel ancillary factor ofmammalian ATP synthase, " Biochimica et Biophysica Acta, vol. 1787, no. 5, pp. 529-532, 2009.
30. Y. Zhuang, M. Yasinta, C. Hu, et al., "Mitochondrial dysfunction confers albumin-inducedNLRP3 inflammasome activation and renal tubular injury, " American Journal of Physiology-Renal Physiology, vol. 308, no. 8, pp. F857-F866, 2015.
31. Y. Zhuang, G. Ding, M. Zhao, et al., "NLRP3 inflammasome mediates albumin-induced renal tubular injury through impaired mitochondrial function, " The Journal of Biological Chemistry, vol. 289, no. 36, pp. 25101-25111, 2014.
32. W. Gong, S. Mao, J. Yu, et al., "NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mousewith 5/6 nephrectomy, "American Journal of Physiology-Renal Physiology, vol. 310, no. 10, pp. F1081-F1088, 2016.
33. R. Zell, P. Geck, K. Werdan, P. Boekstegers, "TNF- and IL-1 inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function, "Molecular and Cellular Biochemistry, vol. 177, no. 1-2, pp. 61-67, 1997.
34. K. Nakahira, J. A. Haspel, V. A. K. Rathinam, et al., "Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome, " Nature Immunology, vol. 12, no. 3, pp. 222-230, 2011.